Results 51 to 60 of about 174,156 (175)

Expression and regulation of antimicrobial peptides in mucosal immunity [PDF]

open access: yes, 2012
Antimicrobial polypeptides (AMPs) are effector molecules of the innate immune defense. AMPs are mainly expressed in epithelial cells and immune cells, providing the first line of defense to infection as direct antimicrobials.
Cederlund, Andreas
core   +1 more source

Recurrent pneumonia with mild hypogammaglobulinemia diagnosed as X-linked agammaglobulinemia in adults [PDF]

open access: yes, 2001
Background X-linked agammaglobulinemia (XLA) is a humoral immunodeficiency caused by disruption of the Bruton's tyrosine kinase (BTK) gene. Typical XLA patients suffer recurrent and severe bacterial infections in childhood.
Hagiwara, Koichi   +7 more
core   +3 more sources

The physical health and quality of life of patients with X-linked agammaglobulinaemia in England and Wales [PDF]

open access: yes, 2020
Ph. D. Thesis.Background Patients with X-linked agammaglobulinaemia (XLA) have absent peripheral circulating Blymphocytes and agammaglobulinaemia caused by defects in BTK. Treatment consists of life-long immunoglobulin replacement therapy.
Shillitoe, Benjamin Martin James
core  

B lymphocytes as effector cells in the immunotherapy of cancer [PDF]

open access: yes, 2011
Over the years, the role of B cells in the host immune response to malignancy has been overshadowed by our focus on T cells. Nevertheless, B cells play important roles as antigen‐presenting cells and in the production of antibodies.
Chang, Alfred E.   +8 more
core   +1 more source

Gene editing in haematopoietic stem cells for the treatment of X-Linked Agammaglobulinaemia [PDF]

open access: yes
This project was a pre-clinical feasibility study to design a gene editing strategy for X-Linked Agammaglobulinaemia (XLA). This affects roughly 1 in 250,000 births and is caused by a mutation in the BTK gene.
Bahal, Sameer
core  

Molecular studies on Burton's tyrosine kinase [PDF]

open access: yes, 1999
X-Linked agammaglobulinaemia (XLA) is a humoral immunodeficiency resulting from a block in the B cell maturation pathway at the pre-B cell stage. Affected males have normal numbers of pre-B cells in the bone marrow but virtually no mature B cells in the ...
Gaspar, Hubert Baburaj
core  

A Case of Fabry's Disease with Congenital Agammaglobulinemia [PDF]

open access: yes, 2011
Fabry's disease is an X-linked lysosomal storage disorder caused by abnormalities in the α-galactosidase A (GLA) gene, which leads to a GLA deficiency and to the intracellular deposition of globotriaosylceramide (Gb3) within vascular endothelium and ...
Bernstein   +22 more
core   +2 more sources

Recurrent infections in a five year old boy [PDF]

open access: yes, 2014
Children are prone to develop recurrent illness in the form of upper respiratory tract infections, gastroenteritis, pustulosis and otitis media owing to developing immunity and environmental exposures.
Goyal , S, Goyal, V
core   +1 more source

Expression of Bruton's tyrosine kinase gene and endoplasmic reticulum stress sensors in X-linked agammaglobulinemia [PDF]

open access: yes, 2018
Orientador: Maria Marluce dos Santos VilelaTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências MédicasResumo: A agamaglobulinemia ligada ao X (XLA; OMIM#300755) é caracterizada por um bloqueio na diferenciação dos linfócitos B na ...
Ramalho, Vanessa Domingues, 1985-
core  

Functional interaction between CD180 Toll-like receptor (TLR) and B cell receptor (BCR) in the biology of Chronic Lymphocytic Leukaemia (CLL) [PDF]

open access: yes, 2017
Chronic Lymphocytic Leukaemia (CLL) is the most common leukaemia in the western world and remains incurable. It is driven by as yet unknown (auto)antigens via the B cell receptor (BCR) and growth, survival and expansion signals it receives from the ...
Rajakaruna, A., Rajakaruna, A.
core  

Home - About - Disclaimer - Privacy